Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cashflow Statement

AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,399 Cr₹569 Cr₹868 Cr₹1,441 Cr₹1,382 Cr
Adjustment ₹982 Cr₹1,010 Cr₹1,472 Cr₹787 Cr₹645 Cr
Changes In working Capital ₹-2,529 Cr₹-797 Cr₹-1,074 Cr₹-561 Cr₹-386 Cr
Cash Flow after changes in Working Capital ₹-147 Cr₹782 Cr₹1,266 Cr₹1,667 Cr₹1,641 Cr
Cash Flow from Operating Activities ₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr
Cash Flow from Investing Activities ₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr
Cash Flow from Financing Activities ₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr
Net Cash Inflow / Outflow ₹-38 Cr₹389 Cr₹19 Cr₹255 Cr₹14 Cr
Opening Cash & Cash Equivalents ₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr₹1,110 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --₹0.67 Cr--
Cash & Cash Equivalent of Subsidiaries under liquidations -₹-192 Cr---
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹56 Cr₹18 Cr₹12 Cr₹18 Cr₹14 Cr
Closing Cash & Cash Equivalent ₹1,676 Cr₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr

Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,740.1 Cr 1% -5% 36.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1%

-5%

36.9%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses